
Chinese General Practice ›› 2026, Vol. 29 ›› Issue (26): 3798-3804.DOI: 10.12114/j.issn.1007-9572.2024.0582
• Article • Previous Articles Next Articles
Received:2024-11-10
Revised:2024-12-30
Published:2026-09-15
Online:2026-08-11
Contact:
GUO Bin
通讯作者:
郭斌
作者简介:作者贡献:
尚颖参与设计实验实施方案,并进行动物造模、行为学干预及数据分析,并撰写文章草稿;王菲、黄雅琪参与设计实验实施方案,进行动物造模、行为学干预、取材、数据收集;马小宁参与数据收集、统计分析;张生富参与行为学干预、取材、数据收集;许能贵、郭斌参与设计文章的研究思路、整体监督管理、审校和质控。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0582
| 名称 | 引物序列 |
|---|---|
| GABA | F:5'-AGTGCCAGAAATTCCCTCCCAAAG-3' R:5'-CAATCAGAGCCGAGAACACGAAGG-3' |
| NT3 | F:5'-GGACTGATGCTTGTCACTGTCGTAG-3' R:5'-GCCTCTGCGTGCTGCTGAAG-3' |
| BDNF | F:5'-TGGAACTCGCAATGCCGAACTAC-3' R:5'-TCCTTATGAACCGCCAGCCAATTC-3' |
| GAPDH | F:5'-TGCTGGTGCTGAGTATGTGGTG-3' R:5'-TCTTCTGGGTGGCAGTGATGG-3' |
Table 1 RT-qPCR primer sequence
| 名称 | 引物序列 |
|---|---|
| GABA | F:5'-AGTGCCAGAAATTCCCTCCCAAAG-3' R:5'-CAATCAGAGCCGAGAACACGAAGG-3' |
| NT3 | F:5'-GGACTGATGCTTGTCACTGTCGTAG-3' R:5'-GCCTCTGCGTGCTGCTGAAG-3' |
| BDNF | F:5'-TGGAACTCGCAATGCCGAACTAC-3' R:5'-TCCTTATGAACCGCCAGCCAATTC-3' |
| GAPDH | F:5'-TGCTGGTGCTGAGTATGTGGTG-3' R:5'-TCTTCTGGGTGGCAGTGATGG-3' |
| 分组 | 足迹平均强度(AU) | 最大触地面积(cm2) | 摆动速度(cm/s) | 三支撑时相比 | 四足支撑百分比 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 建模后第3天 | 造模后第6天 | 建模后第3天 | 造模后第6天 | 建模后第3天 | 造模后第6天 | 建模后第3天 | 造模后第6天 | 建模后第3天 | 造模后第6天 | |
| 空白组 | 40.71±10.74 | 49.62±13.81 | 1.24±0.39 | 1.65±0.44 | 100.89±11.76 | 142.58±13.65 | 67.27±7.80 | 72.18±13.72 | 9.67±7.35 | 5.64±4.60 |
| 模型组 | 49.00±7.12a | 52.43±9.61 | 0.72±0.20a | 1.27±0.28 | 89.65±7.08 | 102.81±21.44a | 57.51±15.54 | 65.44±14.80 | 17.71±11.82 | 6.82±6.41 |
| 电针组 | 46.85±5.91 | 50.16±12.91 | 0.90±0.26 | 1.11±0.53 | 98.50±17.27 | 97.52±35.81a | 67.65±11.53 | 55.61±16.25a | 12.83±10.35 | 8.94±7.62 |
| 巴氯芬组 | 53.33±4.78a | 54.27±6.76 | 1.16±0.37 | 1.54±0.51 | 103.13±49.89 | 121.84±32.51 | 64.02±13.65 | 72.04±10.18 | 11.11±6.40 | 7.15±3.95 |
| 中药组 | 41.75±5.67 | 48.19±3.54 | 0.93±0.29 | 1.10±0.36 | 91.61±26.74 | 101.48±15.80a | 58.99±10.20 | 73.10±8.33 | 11.77±9.59 | 3.14±5.08 |
| 针药组 | 56.54±6.60b | 51.41±4.99 | 1.23±0.50 | 1.46±0.40 | 103.55±33.70 | 120.64±23.56 | 60.24±17.53 | 63.77±8.42 | 10.20±8.10 | 12.19±5.18a |
| F值 | 5.277 | 0.380 | 2.581 | 2.200 | 0.342 | 3.409 | 0.800 | 2.466 | 0.721 | 2.447 |
| P值 | 0.001 | 0.859 | 0.043 | 0.072 | 0.884 | 0.011 | 0.557 | 0.048 | 0.612 | 0.049 |
Table 2 Catwalk gait analysis of rats in six groups after modeling
| 分组 | 足迹平均强度(AU) | 最大触地面积(cm2) | 摆动速度(cm/s) | 三支撑时相比 | 四足支撑百分比 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 建模后第3天 | 造模后第6天 | 建模后第3天 | 造模后第6天 | 建模后第3天 | 造模后第6天 | 建模后第3天 | 造模后第6天 | 建模后第3天 | 造模后第6天 | |
| 空白组 | 40.71±10.74 | 49.62±13.81 | 1.24±0.39 | 1.65±0.44 | 100.89±11.76 | 142.58±13.65 | 67.27±7.80 | 72.18±13.72 | 9.67±7.35 | 5.64±4.60 |
| 模型组 | 49.00±7.12a | 52.43±9.61 | 0.72±0.20a | 1.27±0.28 | 89.65±7.08 | 102.81±21.44a | 57.51±15.54 | 65.44±14.80 | 17.71±11.82 | 6.82±6.41 |
| 电针组 | 46.85±5.91 | 50.16±12.91 | 0.90±0.26 | 1.11±0.53 | 98.50±17.27 | 97.52±35.81a | 67.65±11.53 | 55.61±16.25a | 12.83±10.35 | 8.94±7.62 |
| 巴氯芬组 | 53.33±4.78a | 54.27±6.76 | 1.16±0.37 | 1.54±0.51 | 103.13±49.89 | 121.84±32.51 | 64.02±13.65 | 72.04±10.18 | 11.11±6.40 | 7.15±3.95 |
| 中药组 | 41.75±5.67 | 48.19±3.54 | 0.93±0.29 | 1.10±0.36 | 91.61±26.74 | 101.48±15.80a | 58.99±10.20 | 73.10±8.33 | 11.77±9.59 | 3.14±5.08 |
| 针药组 | 56.54±6.60b | 51.41±4.99 | 1.23±0.50 | 1.46±0.40 | 103.55±33.70 | 120.64±23.56 | 60.24±17.53 | 63.77±8.42 | 10.20±8.10 | 12.19±5.18a |
| F值 | 5.277 | 0.380 | 2.581 | 2.200 | 0.342 | 3.409 | 0.800 | 2.466 | 0.721 | 2.447 |
| P值 | 0.001 | 0.859 | 0.043 | 0.072 | 0.884 | 0.011 | 0.557 | 0.048 | 0.612 | 0.049 |
| 组别 | GABA | NT3 | BDNF |
|---|---|---|---|
| 空白组 | 1.12±0.26 | 0.69±0.34 | 1.00±0.20 |
| 模型组 | 0.98±0.32 | 0.75±0.15 | 1.32±0.83 |
| 电针组 | 0.94±0.29 | 0.51±0.27 | 1.34±0.62 |
| 巴氯芬组 | 0.60±0.19a | 0.55±0.24 | 1.24±0.61 |
| 中药组 | 1.22±0.38 | 0.81±0.40 | 1.14±0.43 |
| 针药组 | 0.55±0.27a | 0.60±0.21 | 2.21±0.92a |
| F值 | 5.172 | 1.104 | 2.618 |
| P值 | 0.002 | 0.379 | 0.044 |
Table 3 Comparison of GABA, NT3, and BDNF mRNA expression levels in the M1 region of 6 groups of rats
| 组别 | GABA | NT3 | BDNF |
|---|---|---|---|
| 空白组 | 1.12±0.26 | 0.69±0.34 | 1.00±0.20 |
| 模型组 | 0.98±0.32 | 0.75±0.15 | 1.32±0.83 |
| 电针组 | 0.94±0.29 | 0.51±0.27 | 1.34±0.62 |
| 巴氯芬组 | 0.60±0.19a | 0.55±0.24 | 1.24±0.61 |
| 中药组 | 1.22±0.38 | 0.81±0.40 | 1.14±0.43 |
| 针药组 | 0.55±0.27a | 0.60±0.21 | 2.21±0.92a |
| F值 | 5.172 | 1.104 | 2.618 |
| P值 | 0.002 | 0.379 | 0.044 |
| 组别 | GABA/β-actin | NT3/β-actin | BDNF/β-actin |
|---|---|---|---|
| 空白组 | 0.92±0.05 | 0.98±0.11 | 1.01±0.11 |
| 模型组 | 0.21±0.04a | 0.11±0.07a | 0.28±0.02a |
| 电针组 | 0.59±0.03a | 0.58±0.04a | 0.60±0.04a |
| 巴氯芬组 | 0.60±0.04a | 0.61±0.06a | 0.61±0.04a |
| 中药组 | 0.84±0.04b | 0.87±0.13b | 0.82±0.07b |
| 针药组 | 0.94±0.12b | 0.92±0.22b | 0.90±0.08b |
| F值 | 84.145 | 26.727 | 59.912 |
| P值 | <0.001 | <0.001 | <0.001 |
Table 4 Comparison of relative protein levels of GABA, NT3, and BDNF in the M1 region among six groups of rats
| 组别 | GABA/β-actin | NT3/β-actin | BDNF/β-actin |
|---|---|---|---|
| 空白组 | 0.92±0.05 | 0.98±0.11 | 1.01±0.11 |
| 模型组 | 0.21±0.04a | 0.11±0.07a | 0.28±0.02a |
| 电针组 | 0.59±0.03a | 0.58±0.04a | 0.60±0.04a |
| 巴氯芬组 | 0.60±0.04a | 0.61±0.06a | 0.61±0.04a |
| 中药组 | 0.84±0.04b | 0.87±0.13b | 0.82±0.07b |
| 针药组 | 0.94±0.12b | 0.92±0.22b | 0.90±0.08b |
| F值 | 84.145 | 26.727 | 59.912 |
| P值 | <0.001 | <0.001 | <0.001 |
| [1] |
张秦墉, 马良宵, 王俊翔, 等. 运动头针法抗卒中后痉挛效应的电生理机制研究[J]. 针刺研究, 2023, 48(10): 986-992.
|
| [2] |
李梦佳, 徐西元. 中西医治疗脑卒中后肢体痉挛性瘫痪概述[J]. 河南中医, 2023, 43(6): 948-956.
|
| [3] |
朱飞叶, 谢冠群, 徐珊. 芍药甘草汤对慢传输型便秘大鼠SCF/c-kit信号途径的影响[J]. 中华中医药杂志, 2016, 31(6): 2331-2333.
|
| [4] |
张芳, 仝秀清, 汪瑞霞. 加味芍药甘草汤联合针刺治疗脑卒中后肌痉挛疗效观察[J]. 四川中医, 2022, 40(11): 154-156.
|
| [5] |
晏振东, 李艳鹏, 张佳琪, 等. 从芍药甘草汤方证与药量探讨胞轮振跳的治疗[J]. 中国中医眼科杂志, 2024, 34(1): 53-55.
|
| [6] |
何毅豪, 王冰, 杨骏, 等. 基于网络药理学和体外细胞实验探讨芍药甘草汤治疗溃疡性结肠炎的作用机制[J]. 上海中医药大学学报, 2022, 36(6): 59-69. DOI: 10.16306/j.1008-861x.2022.06.010.
|
| [7] |
|
| [8] |
郭斌, 王彭汉, 黄麟荇, 等. 电针、加味芍药甘草汤及针药结合对脑卒中肢体痉挛模型大鼠海马突触超微结构及可塑性蛋白的影响[J]. 中医杂志, 2021, 62(2): 151-157.
|
| [9] |
李梴. 医学入门[J]. 养生月刊, 2017, 38(6): 527-529.
|
| [10] |
|
| [11] |
周彤. 成年SD大鼠痉挛性脑损伤模型的建立和健侧颈7神经移位治疗痉挛性脑损伤致手部畸形的临床研究[D]. 石家庄: 河北医科大学, 2021.
|
| [12] |
郭斌, 李海龙, 武润博, 等. 电针促进加味芍药甘草汤缓解大鼠脑卒中痉挛状态的疗效及作用机制[J]. 北京中医药大学学报, 2021, 44(8): 753-763. DOI: 10.3969/j.issn.1006-2157.2021.08.012.
|
| [13] |
李垚, 陈学进. 医学实验动物学[M]. 上海: 上海交通大学出版社, 2019.
|
| [14] |
郭义. 实验针灸学[M]. 北京: 中国中医药出版社, 2008.
|
| [15] |
|
| [16] |
刘同慎, 李冰, 罗慧琼, 等. 尼氏体的甲苯胺蓝组织块染色法[J]. 解剖学杂志, 2018, 41(4): 474-476.
|
| [17] |
吴勉华, 石岩. 中医内科学[M]. 5版. 北京: 中国中医药出版社, 2021.
|
| [18] |
吴霞, 谭金曲, 沈福隆, 等. 曲池穴主治病症的古代文献研究[J]. 中医药临床杂志, 2021, 33(7): 1285-1290.
|
| [19] |
国家中医药管理局关于发布《古代经典名方目录(第一批)》的通知[EB/OL].(2018-04-13)[2024-11-01].
|
| [20] |
惠晨阳, 李晓东, 李恒飞, 等. 芍药甘草汤的古籍文献研究[J]. 中西医结合肝病杂志, 2022, 32(5): 432-435.
|
| [21] |
冯利梅. 芍药甘草汤治疗神经病理性疼痛的物质基础与作用机制研究[D]. 咸阳: 陕西中医药大学, 2021.
|
| [22] |
张颖, 高宁沁, 李擎, 等. 芍药甘草汤联合运动训练治疗脑卒中偏瘫肘关节屈曲痉挛的临床分层研究[J]. 中华物理医学与康复杂志, 2015, 37(2): 107-111.
|
| [23] |
陆军伟, 王云, 周淼, 等. 醒脑开窍针刺法联合加味芍药汤治疗脑卒中后肢体痉挛的临床疗效[J]. 南京中医药大学学报, 2023, 39(11): 1129-1133. DOI: 10.14148/j.issn.1672-0482.2023.1129.
|
| [24] |
刘巍. 基于miR-124-CREB-BDNF-ERK信号通路介导运动训练促进脑梗死大鼠内源性神经干细胞的增殖[D]. 广州: 南方医科大学, 2018.
|
| [25] |
|
| [26] |
杜莉莎. 三维动画中四足动物运动规律及动作表现研究[D]. 重庆: 四川美术学院, 2021.
|
| [27] |
|
| [28] |
陈旭, 张毅, 侯文, 等. 探讨补肾填精益髓方对大鼠脑出血后GFAP、尼氏小体表达水平的影响[C]//第十五届中国医师协会神经外科医师年会摘要集. 深圳, 2020: 136-146.
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
黄慧源, 易丽贞, 黄麟荇, 等. 电针调控小胶质细胞极化抑制脑卒中肢体痉挛大鼠脑皮质炎症反应的研究[J]. 湖南中医药大学学报, 2023, 43(12): 2256-2263.
|
| [40] |
|
| [1] | LIN Yansheng, ZHANG Shuyang, LIN Jiaying, ZHU Jie, ZHOU Yuxin, LIN Jiali, JIA Jie. Correlation of Upper Limb Somatosensory Function and Attention, and Memory in Stroke Patients with Different Sides of Hemiplegia [J]. Chinese General Practice, 2026, 29(26): 3752-3759. |
| [2] | JI Changmeng, XU Sihui, LI Tianhu, DING Yong, WANG Weiqiang. Efficacy of Low-frequency Repetitive Transcranial Magnetic Stimulation Combined with Transcutaneous Electrical Acupoint Stimulation for the Treatment of Upper Limb Motor Impairment in Post-stroke Patients: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(23): 3275-3280. |
| [3] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [4] | LIU Ying, LIU Shiwei, ZHANG Chi, SHEN Ji, ZHANG Yushan, ZHANG Jie, SANG Yingchen, WANG Youjiao, WANG Lei, ZHOU Houguang, SHI Hong. Prevalence and Associated Factors of Subjective Cognitive Decline among Older Stroke Patients in China [J]. Chinese General Practice, 2026, 29(20): 2829-2835. |
| [5] | WU Ruining, ZHOU Ming, ZHANG Gongzi, LI Jun, XIE Suhang, LIU Yangxiaoxue, ZHANG Jiali, LIU Maomao, HUANG Liping. Study on Fixed and Mobile Exoskeleton Robots in Improving Lower Limb Function and Quality of Life in Stroke Patients: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(17): 2326-2333. |
| [6] | JI Ying, GUO Chuan, ZHU Shizhe, JI Panpan, WANG Tong, KAN Chaojie, WANG Qinglei. Effects of Intermittent Theta Burst Stimulation of the Cerebellum on Different Balance Abilities in Patients with Supratentorial Stroke: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(15): 2022-2028. |
| [7] | TIAN Anni, YANG Jing, SUN Jing, WANG Shichun. Effect of Robot-assisted Training on the Recovery of Hand Motor Function in Patients with Different Stages of Stroke: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1911-1920. |
| [8] | HAN Yue, BIAN Zhe, GU Haochen, WANG Dali, PENG Yanbo. Impact of Cumulative Defined Daily Dose of Statins on Recurrence Risk in Ischemic Stroke Patients [J]. Chinese General Practice, 2026, 29(14): 1821-1826. |
| [9] | LIU Yang, LIANG Fang, WU Ling, LI Wenlei, LI Pengfei. Diagnostic Value of Non-conventional Lipids and the Triglyceride-glucose Index in First-onset Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(11): 1422-1429. |
| [10] | Dongfang Hospital, Beijing University of Chinese Medicine, Chinese Sleep Research Society Special Committee on Traditional Chinese Medicine Sleep Medicine. Technical Specification for Electroacupuncture Therapy in Treating Chronic Insomnia [J]. Chinese General Practice, 2026, 29(11): 1367-1373. |
| [11] | WANG Xiaonan, RUAN Xiaonan, LIU Yang, WU Kang, QIU Hua, LIU Qingping, SONG Jiahui, GAO Jiaojiao, ZHOU Yi, LIU Xiaolin. Correlation between Anthropometric Indices and the Risk of Stroke: a Nested Case-control Study [J]. Chinese General Practice, 2026, 29(08): 1020-1028. |
| [12] | CAO Lei, LIU Xuechun, JIANG Wei, CHEN Yan, YAN Sunhong, DU Jing. Study on the Prediction of Muscle Attenuation in Patients with Acute Ischemic Stroke by the Cross-sectional Area and Thickness of the Temporalis Muscle [J]. Chinese General Practice, 2026, 29(08): 997-1007. |
| [13] | HU Naixiao, ZHANG Hao, WANG Bo, QI Xin, DONG Jianhong, XUE Ruizhong, ZHANG Qingsu. Study of the Therapeutic Effect of Intraoral Balloon Dilation Combined with K-point Stimulation in Patients with Post-stroke Pseudobulbar Palsy Associated Dysphagia and Trismus [J]. Chinese General Practice, 2026, 29(05): 591-596. |
| [14] | ZHAO Xuejiao, LI Juan, LI Yujie, LU Ting, Xian Lihong, YAN Huan. Prevalence Trends and Influencing Factors for Post-stroke Cognitive Impairment in China: a Meta-analysis [J]. Chinese General Practice, 2026, 29(03): 380-392. |
| [15] | FAN Zhuanzhuan, LI Wenting, MA Guoliang. Relationship between the Chinese Visceral Adipose Index and Cardiovascular Disease in Postmenopausal Women: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(02): 180-187. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||